{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:55:24Z","timestamp":1787014524440,"version":"build-2736575974"},"reference-count":32,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1728,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1365-2796.2010.02284.x","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T04:13:34Z","timestamp":1283400814000},"page":"299-305","source":"Crossref","is-referenced-by-count":34,"title":["Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening"],"prefix":"10.1111","volume":"269","author":[{"given":"A.","family":"Kjellman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Akre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"H\u00f8yer-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lilja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Norming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Piironen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"T\u00f6rnblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,8]]},"reference":[{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.clinbiochem.2004.05.013","article-title":"The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer","volume":"37","author":"Duffy","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0037-1615846","article-title":"Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system","volume":"82","author":"Blasi","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2174\/1381612033454630","article-title":"Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor","volume":"9","author":"Ploug","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/ijc.20665","article-title":"Expression of urokinase plasminogen activator, its receptor and type-1 inhibitor in malignant and benign prostate tissue","volume":"113","author":"Usher","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB5|cit5","first-page":"1843","article-title":"The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients","volume":"58","author":"Sier","year":"1998","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB6|cit6","first-page":"1132","article-title":"Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer","volume":"8","author":"Riisbro","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1600-0463.2009.02533.x","article-title":"Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer","volume":"117","author":"Almasi","year":"2009","journal-title":"APMIS"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1054\/bjoc.2001.1867","article-title":"Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours","volume":"85","author":"de Witte","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1200\/JCO.2006.05.6853","article-title":"Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis","volume":"25","author":"Shariat","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/ijc.22427","article-title":"Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy","volume":"120","author":"Steuber","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1469-0691.2004.00850.x","article-title":"The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality","volume":"10","author":"Wittenhagen","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijid.2007.02.001","article-title":"Correlates for disease progression and prognosis during concurrent HIV\/TB infection","volume":"11","author":"Djoba Siawaya","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10096-007-0447-5","article-title":"Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor","volume":"27","author":"Kofoed","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1301\/nr.2007.dec.S253-S259","article-title":"Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity","volume":"65","author":"Ridker","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"18224","DOI":"10.1016\/S0021-9258(19)37176-5","article-title":"Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain","volume":"267","author":"Hoyer-Hansen","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1093\/emboj\/19.17.4817","article-title":"Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis","volume":"19","author":"Zhou","year":"2000","journal-title":"EMBO J"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1158\/1078-0432.CCR-08-0096","article-title":"Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer","volume":"14","author":"Henic","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0022-5347(17)37041-6","article-title":"Diagnostic methods in the detection of prostate cancer: a study of a randomly selected population of 2,400 men","volume":"148","author":"Gustafsson","year":"1992","journal-title":"J Urol"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.juro.2008.11.115","article-title":"A 15-year followup of a population based prostate cancer screening study","volume":"181","author":"Kjellman","year":"2009","journal-title":"J Urol"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1373\/clinchem.2004.038232","article-title":"Specific immunoassays for detection of intact and cleaved forms of the urokinase receptor","volume":"50","author":"Piironen","year":"2004","journal-title":"Clin Chem"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1373\/clinchem.2005.064253","article-title":"Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum","volume":"52","author":"Piironen","year":"2006","journal-title":"Clin Chem"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/140349489402200108","article-title":"Malignant disease observed in a cohort of women. A validation of Swedish Cancer Registry data","volume":"22","author":"Helgesson","year":"1994","journal-title":"Scand J Soc Med"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/02841868409136026","article-title":"Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978","volume":"23","author":"Mattsson","year":"1984","journal-title":"Acta Radiol Oncol"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/02813438809009318","article-title":"A validation of cause of death certification for ischaemic heart disease in two Swedish municipalities","volume":"6","author":"Sundman","year":"1988","journal-title":"Scand J Prim Health Care"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.clinbiochem.2009.09.028","article-title":"Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability","volume":"43","author":"Olson","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.thromres.2007.01.011","article-title":"Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients","volume":"120","author":"Pawlak","year":"2007","journal-title":"Thromb Res"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/j.atherosclerosis.2007.06.025","article-title":"Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophages through activation of SREBP-1 in a PI3-kinase and MEK-dependent manner","volume":"195","author":"Fuhrman","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1055\/s-0037-1616105","article-title":"Release of soluble urokinase receptor from vascular cells","volume":"86","author":"Chavakis","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1160\/TH06-11-0669","article-title":"uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist\u2019s view","volume":"97","author":"Binder","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jmv.21114","article-title":"Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy","volume":"80","author":"Andersen","year":"2008","journal-title":"J Med Virol"},{"key":"10.1111\/j.1365-2796.2010.02284.x-BIB32|cit32","first-page":"185","article-title":"suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion","volume":"32","author":"Piccolella","year":"2008","journal-title":"Int J Oncol"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2010.02284.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2796.2010.02284.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T19:44:45Z","timestamp":1636314285000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2010.02284.x"}},"subtitle":["suPAR: a prognostic marker for overall survival"],"short-title":[],"issued":{"date-parts":[[2010,12,8]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02284.x","relation":{},"ISSN":["0954-6820"],"issn-type":[{"value":"0954-6820","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,8]]}}}